Induction of apoptosis but not G1 arrest by expression of the wild- type p53 gene in small cell lung carcinoma

Cell Growth and Differentiation

Volumn 7, Issue 7, 1996, Pages 879-886

  Adachi, Jun Ichi ^a   Ookawa, Keizou ^b   Shiseki, Masayuki ^a   Okazaki, Tomoko ^a   Tsuchida, Shigeki ^b   Morishita, Kazuhiro ^a   Yokota, Jun ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CHROMOSOME 3P; COLONY FORMATION; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MOLECULAR GENETICS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; CELL CULTURE; GENE TRANSFER; GENETICS; LUNG TUMOR; MUTATION; PATHOLOGY; SMALL CELL CARCINOMA;

APOPTOSIS; CARCINOMA, SMALL CELL; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TRANSFER TECHNIQUES; HUMANS; LUNG NEOPLASMS; MUTATION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029657767     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Nigro, J. M., Baker, S. J., Preisinger, A. G., Jessup, J. M., Hostetter, R., Cleary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F. S., Weston, A., Modali, R., Harris, C. C., and Vogelstein, B. Mutations in the p53 gene occur in diverse human tumor types. Nature (Lond.), 342: 705-708, 1989.
2. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
3. Levine, A. J., Momand, J., and Finlay, C. A. The p53 tumor suppressor gene. Nature (Lond.), 357: 453-456, 1991.
4. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavenee, W., and Vogelstein, B. Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature (Lond.), 355: 846-847, 1992.
5. Vogelstein, B., and Kinzler, K. W. p53 function and dysfunction. Cell, 70: 523-526, 1992.
6. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
7. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K., and Vogelstein, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912-915, 1990.
8. Mercer, W. E., Shields, M. T., Amin, M., Sauve, G. J., Appella, E., Romano, J. W., and Ullrich, S. J. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc. Natl. Acad. Sci. USA, 87: 6166-6170, 1990.
9. Chen, P-L, Chen, Y., Bookstein, R., and Lee, W-H. Genetic mechanisms of tumor suppression by the human p53 gene. Science (Washington DC), 250: 1576-1580, 1990.
10. Casey, G., Lo-Hsueh, M. E., Vogelstein, B., and Stanbridge, E. J. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene, 6: 1791-1797, 1991.
11. Takahashi, T., Carbone, D., Takahashi, T., Nau, M. M., Hida, T., Linnoila, I., Ueda, R., and Minna, J. D. Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res., 52: 2340-2343, 1992.
12. Fujiwara, T., Grimm, E. A., Mukhopadhyay, T., Cai, D. W., Owen-Schaub, L. B., and Roth, J. A. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Cancer Res., 53: 4129-4133, 1993.
13. Liu, T-J., Zhang, W-W., Taylor, D. L., Roth, J. A., Goepfert, H., and Clayman, G. L. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res., 54: 3662-3667, 1994.
14. Michalovitz, D., Halevy, O, and Oren, M. Conditional inhibition of transformation and cell proliferation by a temperature-sensitive mutant of p53. Cell, 62. 671-680, 1990.
15. 1 phase. Proc. Natl. Acad. Sci. USA, 89: 9210-9214, 1992.
16. Diller, L., Kassel, L., Nelson, C. E., Gryka, M. A., Litwak, G., Gebhardt, M., Bressac, B., Ozturk, M., Baker, S. J., Vogelstein, B., and Friend, S. H. p53 functions as a cell cycle control protein in osteocarcinomas. Mol. Cell. Biol., 10: 5772-5781, 1990.
17. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. Induction of apoptosis by wild-type p53 in a human colon tumorderived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
18. Yonish-Rouach, E., Resnitzky, D., Lottern, J., Sachs, L., Kimchi, A., and Oren, M. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature (Lond.), 352: 345-347, 1991.
19. Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., and Minna, J. D. p53: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
20. Sameshima, Y., Matsuno, Y., Hirohashi, S., Shimosato, Y., Mizoguchi, H., Sugimura, T., Terada, M., and Yokota, J. Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene, 7: 451-457, 1992.
21. Yokota, J., Wada, M.. Shimosato, Y., Terada, M., and Sugimura, T. Loss of heterozygosity on chromosome 3, 13, and 17 in small-cell carcinoma and on chromosomes 3 in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA, 84: 9252-9256, 1987.
22. Harbour, J. W., Lai, S-L, Whang-Peng, J., Gazdar, A. F., Minna, J. D., and Kaye, F. J. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science (Washington DC), 247: 353-357, 1988.
23. Yokota, J., Akiyama, T., Fung, Y-K., Benedict, W. F., Namba, Y., Hanaoka, M., Wada, M., Terasaki, T., Shimosato, Y., Sugimura, T., and Terada, M. Altered expression of the retinoblastoma (RB) gene in smallcell carcinoma of the lung. Oncogene, 3: 471-475, 1988.
24. Mori, N., Yokota, J., Oshimura, M., Cavenee, W. K., Mizoguchi, H., Noguchi, M., Shimosato, Y., Sugimura, T., and Terada, M. Concordant deletion of chromosome 3p and loss of heterozygosity for chromosomes 13 and 17 in small cell lung carcinoma. Cancer Res., 49: 5130-5135, 1989.
25. Hartwell, L. H., and Kastan, M. B. Cell cycle control and cancer. Science (Washington DC), 266: 1821-1828, 1994.
26. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
27. EI-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF 1, a potential mediator of p53tumor suppression. Cell, 75: 817-825, 1993.
28. 1 cyclindependent kinases. Cell, 75: 805-816, 1993.
29. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
30. Ookawa, K., Shiseki, M., Takahashi, R., Yoshida, Y., Terada, M., and Yokota, J. Reconstitution of the RB gene suppress the growth of smallcell lung carcinoma cells carrying multiple genetic alterations. Oncogene, 8: 2175-2181, 1993.
31. Hinds, P. W., Finlay, C. A., Quartin, R. S., Baker, S. J., Fearon, E. R., Vogelstein, B., and Levine, A. J. Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes. Cell Growth & Differ., 1: 571-580, 1990.
32. Gossen, M., and Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA, 89: 5547-5551, 1992.
33. Williams, B. O., Remington, L., Albert, D. M., Mukai, S., Bronson, R. T., and Jacks, T. Cooperative tumorigenic effects of germline mutations in RB and p53. Nat. Genet., 7: 480-484, 1994.
34. White, E. p53, guardian of Rb. Nature (Lond.), 377: 21-22, 1994.
35. Morgenbesser, S. D., Williams, B. O., Jacks, T., and DePinho, R. A. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature (Lond.), 377: 72-74, 1994.
36. Wu, X., and Levine, A. J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA, 97: 3602-3606, 1994.
37. Yonish-Rouach, E., Borde, J., Marianne, G., Mishal, Z., Viron, A., and May, E. Induction of apoptosis by transiently transfected metabolically stable wt p53 in transformed cell lines. Cell Death Differ., 1: 39-47, 1994.
38. Caelles, C., Helmberg, A., and Karin, M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (Lond.), 370: 220-223, 1994.
39. Yonish-Rouach, E., Deguin, V., Zaitchouk, T., Breugnot, C., Mishal, Z., Jenkins, J. R., and May, E. Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53. Oncogene, 12: 2197-2205, 1996.
40. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 67: 759-767, 1990.
41. Yokota, J., and Sugimura, T. Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J., 7: 920-925, 1993.
42. Huang, H-J. S., Yee, J-K., Shew, J-Y., Chen, P-L., Bookstein, R., Friedmann, T., Lee, E. Y-H. P., and Lee, W-H. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science (Washington DC), 242: 1563-1566, 1988.
43. Goyette, M. C., Cho, K., Fasching, C. L., Levy, D. B. Kinzler, K. W., Paraskeva, C., Vogelstein, B., and Stanbridge, E. J. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell. Biol., 12: 1387-1395, 1992.
44. INK4 gene mediated by an adenovirus vector. Cancer Res., 55: 3250-3253, 1995.
45. Horowitz, J. M., Park, S-H., Bogenmann, E., Cheng, J-C., Yandell, D. W., Kaye, F. J., Minna, J. D., Dryja, T. P., and Weinberg, R. A. Frequent inactivation of the retinoblastoma anti-cncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. USA, 87: 2775-2779, 1990.
46. Hensel, C. H., Hsieh, C-L., Gazdar, A. F., Johnson, B. E., Sakaguchi, A. Y., Naylor, S. L., Lee, W-H., and Lee, E. Y-H. Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res., 50: 3067-3072, 1990.
47. Bodner, S. M., Minna, J. D., Jensen, S. M., D'Amico, D., Carbone, D., Mitsuya, T., Fedorko, J., Buchhagen, D. L., Nau, M. M., Gazdar, A. F., and Linnoila, R. I. Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene, 7: 743-749, 1992.
48. Imai Y., Matsushima Y., Sugimura T., and Terada M. A simple and rapid method for generating a deletion by PCR. Nucleic Acids Res., 19: 2785, 1991.
49. Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
50. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity. J. Immunol. Methods, 65: 55-63, 1983.